CellCept 250 mg hard capsules - each capsule contains 250mg of mycophenolate mofetil. CellCept 500mg film-coated tablets - each tablet contains 500mg
Cellceptcapsuspinf
050723s019
19 févr. 2020 H341 Suspected of causing genetic defects. Page 2. SAFETY DATA SHEET. CELLCEPT(R) Capsules (250 mg).
CELLCEPTCapsules mgSAPSDS
gb-pl-cellcept-220722-clean-250mg Caps. Package Leaflet: Information for the patient. CellCept 250 mg hard capsules mycophenolate mofetil.
pil.
Each capsule contains 250 mg mycophenolate mofetil. For the full list of excipients see section 6.1. 3. PHARMACEUTICAL FORM. Capsules
cellcept epar product information en
14 févr. 1996 Bioequivalence studies were performed for both the 250 mg strength (capsules) and the 500 mg strength (tablets) under fasting and fed conditions ...
mycophenolate mofetil teva epar public assessment report en
14 févr. 1996 Myfenax 500 mg film coated tablet and 250 mg capsule is a generic medicinal product containing mycophenolate mofetil as active substance.
myfenax epar public assessment report en
16.2 CELLCEPT (mycophenolate mofetil capsules) 250 mg. 16.3 CELLCEPT (mycophenolate mofetil tablets) 500 mg. 16.4 CELLCEPT Oral Suspension (mycophenolate
cellcept prescribing
The active substance of CellCept 250 mg capsules is mycophenolate mofetil. The other ingredients of the capsules are pregelatinised maize starch croscarmellose
anx en
CellCept® 20210329. 1. Consumer Medicine Information. CellCept®. Mycophenolate mofetil. 250 mg capsules. 500 mg tablets. 500 mg powder for solution for
Cellcept